BioSpace News Archive

InVita Healthcare Technologies (formerly HemaTerra Technologies), a leading software provider for complex medical environments including blood and plasma collection, is offering its Rapid Rollout program to blood product collectors to assist in their time of need

Medi-Immune, Ltd., have revealed ProtectivAir®, a breathing device which has proven effective against viral and bacterial pathogens and is expected to be similarly effective against SARS-CoV-2.

OneThree Biotech, a biology-driven artificial intelligence platform that optimizes drug discovery and development, announces closing of a $2.5M seed round along with free toxicity screening to any academic or medical researcher working on developing a new drug to treat COVID-19.

Tyto Care’s TytoHome telehealth device enables Deaconess patients to perform comprehensive physical examinations with a Deaconess Care Provider from the comfort of home

AACC commends the U.S. Senate for passing the Coronavirus Aid, Relief, and Economic Security Act yesterday, which will provide vital support to Americans in the midst of the coronavirus outbreak.

Life extension and biomedical simulation and visualization AI company Zenerchi™ LLC (www.SimViz.ai) today announced it has leveraged its platform to create educational and time-sensitive content about the coronavirus pandemic.

Across the country, in large urban areas as well as small rural communities, EMTs and paramedics are serving on the frontlines of our nation’s war against the COVID-19 pandemic, oftentimes without the necessary supplies and equipment to ensure the safety of their patients and themselves.

CardioQuipTM, LLC, a medical device manufacturer focused on development and commercialization of patient temperature control and cardiovascular perfusion technology announced today it has received CE Mark approval for the MCH-1000TM Modular Cooler-Heater SeriesTM.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart failure will be shared at this year’s American College of Cardiology and World Congress of Cardiology Virtual meeting (ACC.20/WCC) . In lieu of traditional in-person presentations, ACC.20/WCC will share all abstracts and posters accep

Annual Report, including the Sustainability Report, for the 2019 fiscal year has been published.